Thema: US18914F1030
CLOV, US18914F1030
finance-6097979_1920.jpg - Foto: THN
Clover Health stock draws focus after Q3 profit, guidance lift
Clover Health stock follows a profitable third quarter and higher 2026 targets. Medicare Advantage growth and a five-star PPO rating shape the outlook.
ad-hoc-news.de, vor 46 Minuten
CLOV, US18914F1030
Clover Health stock gains 6.85 percent to EUR 4.21 after ...
Second-quarter revenue reached USD 743.17 million. Clover Health stock costs EUR 4.21 on October 20, 2026, up 6.85 percent versus Tradegate's close.
ad-hoc-news.de, 20.10.26 20:54 Uhr
CLOV, US18914F1030
Six brokerages set a USD 4.75 consensus for Clover Health ...
Results are due on November 4, 2026. Clover Health stock stood at USD 4.48 on October 16, 2026, down 4.27 percent versus the Nasdaq prior close.
ad-hoc-news.de, 17.10.26 21:44 Uhr
CLOV, US18914F1030
Canaccord keeps USD 5.50 target for Clover Health stock
Q2 revenue rose 56.00 percent to USD 743.17 million. Clover Health stock costs EUR 4.18 on October 15, 2026, down 2.09 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 21:38 Uhr
CLOV, US18914F1030
Clover Health sets results date. Deutsche Bank sets USD ...
Clover Health revenue reached USD 743.20 million in the second quarter. Clover Health stock costs EUR 4.10 on October 8, 2026 versus EUR 4.08.
ad-hoc-news.de, 08.10.26 15:35 Uhr
CLOV, US18914F1030
Clover Health stock holds near a 52-week high
Clover Health stock trades around USD 4.15 after Q2 2026 revenue of USD 743.17 million and EPS of USD 0.05. The latest results topped estimates and MarketBeat now shows a ...
ad-hoc-news.de, 02.09.26 13:15 Uhr
Clover, Health
Clover Health Investors Await Crucial Strategy Presentation ...
